| 000 | 01765 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517134458.0 | ||
| 264 | 0 | _c20180119 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/s12936-017-1695-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCisse, Mamoudou | |
| 245 | 0 | 0 |
_aRecent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. _h[electronic resource] |
| 260 |
_bMalaria journal _c01 2017 |
||
| 300 |
_a38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia _xepidemiology |
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 |
_aBurkina Faso _xepidemiology |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xcomplications |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 650 | 0 | 4 |
_aPyrimethamine _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfadoxine _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAwandare, Gordon A | |
| 700 | 1 | _aSoulama, Alamissa | |
| 700 | 1 | _aTinto, Halidou | |
| 700 | 1 | _aHayette, Marie-Pierre | |
| 700 | 1 | _aGuiguemdé, Robert T | |
| 773 | 0 |
_tMalaria journal _gvol. 16 _gno. 1 _gp. 38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-017-1695-1 _zAvailable from publisher's website |
| 999 |
_c26810808 _d26810808 |
||